CALLICUTT JACK W — SEC Form 4 filings
SEC reporting owner CIK 1266773. 10 Form 4 filings on record with FilingPulse; latest filed 2026-01-21.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-07 to 2026-01-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 22 legs across 7 filings — 224,956 shares, $1,035,942 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
- Largest priced transaction: sale of 28,100 shares @ $6.22 ($174,866) in GALECTIN THERAPEUTICS INC, filed 2025-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | Chief Financial Officer | 10 | — | 22 legs · 224,956 sh · $1,035,942 | 46 |
Form 4 filings — CALLICUTT JACK W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-21 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Grant/award (A): 65,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 60,000 @ $0 · Sale (S): 13,914 @ $4.20 · Sale (S): 25,732 @ $3.90 · Sale (S): 20,354 @ $3.67 · Option exercise (M): 60,000 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 9,586 @ $1.98 · Sale (S): 9,586 @ $6.03 · Option exercise (M): 19,701 @ $1.11 · Sale (S): 19,701 @ $6.03 · Option exercise (M): 2,323 @ $1.23 · Sale (S): 2,323 @ $6.03 · +9 more | EDGAR |
| 2025-11-12 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 1,880 @ $1.98 · Sale (S): 1,880 @ $6.02 · Option exercise (M): 1,675 @ $1.11 · Sale (S): 1,675 @ $6.03 · Option exercise (M): 1,736 @ $1.23 · Sale (S): 1,736 @ $6.03 · +3 more | EDGAR |
| 2025-11-07 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 200 @ $1.98 · Sale (S): 200 @ $6 · Option exercise (M): 200 @ $1.11 · Sale (S): 200 @ $6 · Option exercise (M): 200 @ $1.72 · Sale (S): 200 @ $6 · +3 more | EDGAR |
| 2025-11-05 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 1,300 @ $1.98 · Sale (S): 1,300 @ $6.01 · Option exercise (M): 1,260 @ $1.11 · Sale (S): 1,260 @ $6.01 · Option exercise (M): 1,250 @ $1.72 · Sale (S): 1,250 @ $6.01 · +12 more | EDGAR |
| 2025-09-15 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 8,706 @ $1.37 · Sale (S): 8,706 @ $6.44 · Option exercise (M): 8,706 (derivative) @ $1.37 | EDGAR |
| 2025-01-27 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Grant/award (A): 65,000 (derivative) @ $0 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Option exercise (M): 40,000 @ $0 · Sale (S): 40,000 @ $0.89 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2024-02-07 | 4 | GALECTIN THERAPEUTICS INC (GALT) | Grant/award (A): 65,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1266773 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →